MTD vs REPL
Mettler-Toledo International Inc (MTD) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
REPL does not have a complete income-statement cache yet.
MTD currently screens at market cap $23.20B and trailing P/E 26.9. REPL currently screens at market cap $825.7M.
Not investment advice. Open the MTD and REPL stock pages for the full models.
Not investment advice.